ITBIOMETRICS™ Unveils the DOGOOD™ Card Transforming Financial Security and Merchant Savings
ITBIOMETRICS™, a trailblazer in capacitive biometric authentication, is set to revolutionize the cryptocurrency and credit card landscape with its latest innovation, the DOGOOD™ card. This product promises to offer far-reaching benefits to both consumers and card merchants, delivering enhanced security and significant cost savings. It also allows for instantaneous logging in and purchasing of merchandise without passwords, account numbers, and multi-factor authentication and CAPTCHA by substituting biometrics.
For cryptocurrency users, not only does it prevent losses from hacking but also from failed cryptocurrency exchanges by making cryptocurrency ownership far simpler and more secure. It's simpler because there are no 64-character passphrases to remember, and if the user ever loses their ITBx™ cryptocurrency wallet, all they need to do is obtain another wallet, and all of the digital assets they own will reappear. The invention uses the fingerprint itself to encrypt and decrypt information.
Financial transactions are becoming increasingly vulnerable to hacking, including the cryptocurrency market. The result is a financial ecosystem plagued by billions of dollars in losses by card merchants, customers, and cryptocurrency enthusiasts due to fraud and identity theft.
According to Howard Prager , CEO of ITBIOMETRICS™, merchants grapple with a significant percentage of holdback and high card fraud loss chargebacks. ITBIOMETRICS™ recognized these critical pain points and developed the DOGOOD™ card to address them head-on.
The DOGOOD™ card utilizes simultaneously four factors and a fingerprint substitute for the user's password. It ensures that only the rightful owner can authorize transactions. By incorporating four types of biometric sensors, the card verifies the user's identity through fingerprint recognition and a method far more secure than traditional passwords by capturing infrared pictures of the finger flesh. The only thing that the user has to remember is which fingers to use.
"This approach can drastically reduce the risk of fraud and hacking," says Prager. This offers unprecedented protection against unauthorized access. Moreover, the DOGOOD™ card integrates seamlessly with major payment card brands, ensuring widespread acceptance and convenience for users.
Consumers could benefit from enhanced security and peace of mind. It is important to note that the fingerprint never leaves the device. Whatever is sent to credit card merchants and banks, and cryptocurrency exchanges and currencies, are highly encrypted signals. It eliminates the need for remembering complex passwords or PINs, offering a more convenient and secure user experience in seconds. The DOGOOD™ card also provides an optional rebate system, where users accumulate savings throughout the year, which can be distributed on their account anniversary.
"Since the DOGOOD™ card can prevent identity theft and credit card fraud, one of the major card brands estimates that banks can save a significant percentage of their credit card overhead. They can compete with one another for new customers by offering increasingly larger rebates. The reason is that they want to capture debit, as well as credit card business, as they make a profit on each transaction. Some may reduce interest rates on credit cards to compete with consumers who are more sensitive to interest rates," shares Prager.
These rebates can be directed towards personal savings, charitable donations, or tips to companies that have provided exceptional service, creating a culture of generosity and community support. Howard further expresses, "We have created this service for our clients so that they could act like a 'Santa Claus' at least once each year, spreading joy to recipients all year round."
"To understand the scale of the beneficial effects on the economy, major payment platforms collectively earn trillions of dollars a year. It is likely that the typical card merchant will save a significant percentage of their chargebacks. The arithmetic tells us that card merchants collectively can have substantial profits when the DOGOOD™ card becomes ubiquitous," says Prager.
In addition to its financial security benefits, the DOGOOD™ card introduces innovative features to protect users in critical moments. DOGOOD™ is equipped with an AI named SHREEDAAN. That name means 'do good' in Hindi. The integration system provides users with a guardian angel-like AI service. This system appears with a humanlike image with facial recognition and location tracking to identify and respond to potential threats, activating emergency protocols to safeguard the user when using their Panic Finger established during setup.
With necessary certifications like FIDO2 (Fast Id Online), ITBIOMETRICS™ continues to advance its technology.
Media Contact
Name: Howard Prager
Email: hprager@globepays.co
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Int'l Business Times
a day ago
- Int'l Business Times
ITBIOMETRICS™ Unveils the DOGOOD™ Card Transforming Financial Security and Merchant Savings
ITBIOMETRICS™, a trailblazer in capacitive biometric authentication, is set to revolutionize the cryptocurrency and credit card landscape with its latest innovation, the DOGOOD™ card. This product promises to offer far-reaching benefits to both consumers and card merchants, delivering enhanced security and significant cost savings. It also allows for instantaneous logging in and purchasing of merchandise without passwords, account numbers, and multi-factor authentication and CAPTCHA by substituting biometrics. For cryptocurrency users, not only does it prevent losses from hacking but also from failed cryptocurrency exchanges by making cryptocurrency ownership far simpler and more secure. It's simpler because there are no 64-character passphrases to remember, and if the user ever loses their ITBx™ cryptocurrency wallet, all they need to do is obtain another wallet, and all of the digital assets they own will reappear. The invention uses the fingerprint itself to encrypt and decrypt information. Financial transactions are becoming increasingly vulnerable to hacking, including the cryptocurrency market. The result is a financial ecosystem plagued by billions of dollars in losses by card merchants, customers, and cryptocurrency enthusiasts due to fraud and identity theft. According to Howard Prager , CEO of ITBIOMETRICS™, merchants grapple with a significant percentage of holdback and high card fraud loss chargebacks. ITBIOMETRICS™ recognized these critical pain points and developed the DOGOOD™ card to address them head-on. The DOGOOD™ card utilizes simultaneously four factors and a fingerprint substitute for the user's password. It ensures that only the rightful owner can authorize transactions. By incorporating four types of biometric sensors, the card verifies the user's identity through fingerprint recognition and a method far more secure than traditional passwords by capturing infrared pictures of the finger flesh. The only thing that the user has to remember is which fingers to use. "This approach can drastically reduce the risk of fraud and hacking," says Prager. This offers unprecedented protection against unauthorized access. Moreover, the DOGOOD™ card integrates seamlessly with major payment card brands, ensuring widespread acceptance and convenience for users. Consumers could benefit from enhanced security and peace of mind. It is important to note that the fingerprint never leaves the device. Whatever is sent to credit card merchants and banks, and cryptocurrency exchanges and currencies, are highly encrypted signals. It eliminates the need for remembering complex passwords or PINs, offering a more convenient and secure user experience in seconds. The DOGOOD™ card also provides an optional rebate system, where users accumulate savings throughout the year, which can be distributed on their account anniversary. "Since the DOGOOD™ card can prevent identity theft and credit card fraud, one of the major card brands estimates that banks can save a significant percentage of their credit card overhead. They can compete with one another for new customers by offering increasingly larger rebates. The reason is that they want to capture debit, as well as credit card business, as they make a profit on each transaction. Some may reduce interest rates on credit cards to compete with consumers who are more sensitive to interest rates," shares Prager. These rebates can be directed towards personal savings, charitable donations, or tips to companies that have provided exceptional service, creating a culture of generosity and community support. Howard further expresses, "We have created this service for our clients so that they could act like a 'Santa Claus' at least once each year, spreading joy to recipients all year round." "To understand the scale of the beneficial effects on the economy, major payment platforms collectively earn trillions of dollars a year. It is likely that the typical card merchant will save a significant percentage of their chargebacks. The arithmetic tells us that card merchants collectively can have substantial profits when the DOGOOD™ card becomes ubiquitous," says Prager. In addition to its financial security benefits, the DOGOOD™ card introduces innovative features to protect users in critical moments. DOGOOD™ is equipped with an AI named SHREEDAAN. That name means 'do good' in Hindi. The integration system provides users with a guardian angel-like AI service. This system appears with a humanlike image with facial recognition and location tracking to identify and respond to potential threats, activating emergency protocols to safeguard the user when using their Panic Finger established during setup. With necessary certifications like FIDO2 (Fast Id Online), ITBIOMETRICS™ continues to advance its technology. Media Contact Name: Howard Prager Email: hprager@
Int'l Business Times
2 days ago
- Int'l Business Times
Passion, Plants, and Phase III: Devonian Health Group Is on a Mission to Disrupt Inflammation Therapy
While the industry might be dominated by synthetic compounds, billion-dollar VC funds, and long, uncertain development timelines, Devonian Health Group Inc. is proving there is another way. As a publicly traded company, under the leadership of its founder and CEO, Dr. André P. Boulet, Devonian has quietly advanced multi-target drug candidates and a cutting-edge cosmeceutical line, backed not by institutional investors but by a network of Canadian family offices made up of dentists, physicians, engineers, and entrepreneurs. Boulet's journey to this unconventional success story reads like a masterclass in risk, reinvention, and scientific conviction. "I'm a venture capitalist in my heart," Boulet says. "But I'm also a scientist. When I saw the anti-inflammatory results of this botanical extract technology from a university agriculture project, I knew this had real potential. So, I followed my instinct and took the risk." With a PhD in physiology-endocrinology, postdoctoral training in biochemistry and biophysics, and experience leading cardiovascular clinical research programs, Boulet's transition from academia to venture capital was swift. After climbing the pharmaceutical ladder and managing funds in Montreal, he exited his partnership and launched what would become Devonian Health Group in 2015. At its core, Devonian is a clinical-stage pharmaceutical company focused on autoimmune and inflammatory conditions, with its lead drug candidate, Thykamine ™, poised to enter Phase III clinical trials for atopic dermatitis and soon pediatric eczema. "Traditional pharma was built on the 'silver bullet,' one target, one mechanism," Boulet explains. "But now science is evolving. We're moving toward therapies that modulate multiple pathways. That's exactly what Thykamine does without shutting down important immune functions like TNF-alpha. That's why our efficacy is high, but side effects are minimal." What sets Devonian apart isn't just its marquee drug but the platform behind it. The company's patented SUPREX™ technology allows for water-based extraction, purification, and stabilization of Active Botanical Ingredients (ABIs) from plants and algae. These complexes modulate inflammation at the genetic level across multiple diseases, offering a broad pipeline of possibilities. To date, Thykamine™ has demonstrated strong results in its Phase II trial. Both gastrointestinal (ulcerative colitis) and dermatological (eczema) models have shown significant symptom relief and safety comparable to placebo. Remarkably, all this has been achieved without traditional VC backing. Boulet credits this to his deep network of entrepreneurial allies and his belief in business-first partnerships. "We've raised funds to advance to Phase III, built an extraction and production facility, and kept the company debt-free," he says. While the pharmaceutical arm garners headlines, Devonian's cosmeceutical division is equally ambitious. Operating under the Purgenesis™ brand, the company has developed a premium line of anti-aging creams containing its patented botanical ingredient R-Spinasome®, a photosynthetic cell extract with dynamic antioxidant properties. What makes Purgenesis™ unusual in the beauty space is its clinical rigor. Devonian has conducted peer-reviewed, pharma-grade clinical trials on the entire product line, something virtually unheard of in the cosmeceutical industry. "We've scientifically proven a reduction in wrinkles," says Boulet. "Not just pretty pictures, but peer-reviewed, published data. We're the only ones doing cosmeceuticals the pharma way." With day, night, and eye creams already developed and a professional-grade serum in the pipeline, Devonian is currently seeking commercial partners to bring Purgenesis™ to a global market hungry for results-backed skincare. Perhaps the most unusual aspect of Devonian's success is how personal it all feels. There are no Silicon Valley investors or hedge fund suits behind the curtain, just a network of entrepreneurs who believe in the mission. "Working with family offices is stimulating," Boulet says. "You get input from pharmacists, dentists, and industrialists. We face challenges together, and we have fun doing it." The company's headquarters in Québec includes a full-scale extraction and production facility, providing complete traceability from seed to pill. This vertical integration helps with both cutting costs, yes, but also ensuring product consistency. For Boulet, the journey has been one of passion and perseverance. "In life, there's always a risk," he reflects. "But if you surround yourself with the right people and believe in what you're building, that risk becomes your fuel. That's what Devonian is about: science, instinct, and community." As the company readies for Phase III trials in both pharmaceuticals and final-stage commercialization of its skincare line, Devonian Health Group stands as a testament to the power of conviction and the potential of plants to reshape the future of medicine.
Int'l Business Times
12-06-2025
- Int'l Business Times
Breaking Stigma: Stoggles' Mission in Redefining Protective Eyewear for Everyday Life
Many people choose to go without protective gear due to stigma. Whether this stigma comes from external factors or from within doesn't necessarily matter. Whether it's due to the inaccessibility of design-forward solutions in an industry plagued by age-old traditions or simply the image an individual has of themselves, damage is being done, and there is a clear need for a solution. That's the narrative Stoggles, Inc., a design-forward, purpose-driven eyewear company, is determined to reframe. Its goal is to make protective eyewear so seamless, stylish, and versatile that it becomes second nature. Stoggles This mission is urgent, and a look at the broader landscape can attest to that. Every year, roughly 2.4 million eye injuries occur in the United States. It's troubling how 90% of these injuries could be prevented with some form of eye protection. However, there's a twist. The problem isn't always about access to protective gear. It's about the willingness to wear it. "People skip safety glasses for social and psychological reasons," says Stoggles co-founder Rahul Khatri. "They fear judgment from others, worry about how they'll look, or assume that wearing protective eyewear will make them stand out in all the wrong ways." This resistance mirrors the childhood aversion to helmets. Stoggles has seen kids avoid them because they think they look silly and because peer approval weighs heavier than self-preservation. That same mindset, simply aged up, influences how adults think about safety. "Someone pruning roses in their front yard might skip eye protection to avoid awkward glances from neighbors. A member of a running club might pass on safety shades because of outdated gender norms," Max Greenberg, co-founder, adds. The result is a pattern of preventable injuries. That discomfort sparked Stoggles's creation. It was founded to challenge the unspoken assumption that people have to choose between style and safety. The brand's eyewear looks like one's favorite specs but functions like high-performance safety gear. By embedding ANSI Z87-certified protection into sleek, everyday-ready frames, Stoggles makes it easier for people to make the safer choice without feeling like they've compromised their identity. And, with an option to add your prescription, you don't have to choose between safety, style, comfort, or sight. Stoggles The brand's proprietary LucidLens™ is lightweight, shatterproof, blue-light blocking, and sealed with an advanced anti-fog coating on the market. The lenses also block harmful UV rays, helping to prevent long-term issues. With ultra-durable polycarbonate frames, each pair of Stoggles is built to last through the rigors of daily use. Stoggles's blend of function and form empowers those who wear its products. That empowerment is illustrated by the stories of real customers. One of the most memorable came from a heavy equipment operator working in a male-dominated warehouse. "She sent us a handwritten postcard, complete with photos of herself proudly wearing the glasses. Her appreciation made our hearts full, but it's her confidence that really stood out," Khatri recalls. "She felt isolated in her environment, and knowing that our eyewear gave her a sense of comfort motivated us to continue what we're doing." In a male-dominated industry, the empowerment of a single solution can not be underestimated. Khatri adds, "There are products made for men by men, and now, did we just expect women to feel comfortable wearing them? We saw the damage caused by this mindset and created Stoggles to alleviate it. Not by creating a product for women or men, but by creating a product for all." Besides industrial settings, the reach of Stoggles extends to unexpected corners of everyday life. Gardeners, for instance, find them valuable for protecting against dirt, debris, and sharp branches. At the same time, they feel confident about being seen by neighbors or passersby. Meanwhile, runners and members of outdoor clubs appreciate the light, breathable frames, anti-fog solution, and UV protection during long-distance outings. Stoggles allows these users to focus on performance without distraction or discomfort. Stoggles These real-world applications speak to a broader shift that Stoggles aims to help lead. The brand understands that personal identity becomes more tied to how people choose and wear their gear. Stoggles meets the moment with a product that prioritizes self-expression and self-preservation. "Whether an outdoor enthusiast, craft hobbyist, makeup artist, lover of all things sports, avid baker, or even someone affected by allergies, you deserve better," adds Khatri. This vision is an extension of Stoggles's mission to make safety personal, wearable, and aspirational, breaking the stigma and creating a new and empowered society. "We want to help everyone, everywhere, with innovative and seamless design. Through this, we want to create an environment of empowerment, an environment where feeling safe, stylish, and confident aren't mutually exclusive. That is the purpose of Stoggles," concludes Greenberg.
